Literature DB >> 7622818

The behavioural toxicity of the selective serotonin reuptake inhibitors.

I Hindmarch1.   

Abstract

The serotonin reuptake inhibitors (SSRIs) are generally better tolerated than the traditional tricyclic antidepressants (TCAs) in the treatment of major depression. In particular the SSRIs are relatively free from cognitive and psychomotor effects likely to cause behavioural toxicity. Behavioural toxicity is studied using a battery of psychometric assessments. This paper discusses the effects of the TCAs and SSRIs on two such assessments, choice reaction time (CRT) and critical flicker fusion threshold (CFFT). CRT measures psychomotor speed, and CFFT assesses the information processing capacity of the CNS. The behavioural toxicity associated with the traditional TCAs can lead to an increased accident risk, whereas the SSRIs are not associated with such effects. Clinically relevant differences in the behavioural toxicity of the SSRIs are highlighted.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622818     DOI: 10.1097/00004850-199501004-00002

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  7 in total

Review 1.  Drug-induced cognition disorders in the elderly: incidence, prevention and management.

Authors:  S L Gray; K V Lai; E B Larson
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

Review 2.  Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

Authors:  S M Cheer; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task.

Authors:  Emma J Rose; Enrico Simonotto; Edgar P Spencer; Klaus P Ebmeier
Journal:  Psychopharmacology (Berl)       Date:  2006-03-09       Impact factor: 4.530

Review 4.  Tolerability and safety of fluvoxamine and other antidepressants.

Authors:  H G M Westenberg; C Sandner
Journal:  Int J Clin Pract       Date:  2006-04       Impact factor: 2.503

5.  BPSD following traumatic brain injury.

Authors:  Renato Anghinah; Fabio Rios Freire; Fernanda Coelho; Juliana Rhein Lacerda; Magali Taino Schmidt; Vanessa Tomé Gonçalves Calado; Jéssica Natuline Ianof; Sergio Machado; Bruna Velasques; Pedro Ribeiro; Luis Fernando Hindi Basile; Wellingson Silva Paiva; Robson Luis Amorim
Journal:  Dement Neuropsychol       Date:  2013 Jul-Sep

6.  Fluvoxamine in the treatment of anxiety disorders.

Authors:  Jane Irons
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

7.  Time related effects on functional brain connectivity after serotonergic and cholinergic neuromodulation.

Authors:  Bernadet L Klaassens; Serge A R B Rombouts; Anderson M Winkler; Helene C van Gorsel; Jeroen van der Grond; Joop M A van Gerven
Journal:  Hum Brain Mapp       Date:  2016-09-13       Impact factor: 5.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.